Xylose utilization promotes Salmonella replication within macrophages and systemic infection in mice Authors: Xinyue Wang, Yuyang Sun, Houliang Guo, Xiaolin Yan, Shuai Ma, Bin Yang, Lingyan Jiang Published: 2024 ABSTRACT ABSTRACTThe intracellular pathogen Salmonella can cause systemic diseases via its survival and replication in host macrophages. Xylose is the second most abundant sugar in nature and Salmonella can use xylose as its sole carbon source for growth. However, whether xylose utilization contributes to the pathogenicity and intracellular growth of Salmonella has not yet been determined. In this study, we observed that the xylose concentration in macrophages increased during Salmonella infection. Moreover, there was an increase in expression of Salmonella xylose catabolic genes (xylA and xylB) and the transcriptional regulatory gene of xylose metabolism (xylR) in macrophages, revealing the possibility of using host-accumulated xylose by Salmonella for intracellular growth. Mutation of either xylAB or xylR reduced Salmonella replication in macrophages and attenuated the colonization of mouse systemic loci (e.g. the liver and spleen), indicating that xylose utilization promotes Salmonella replication within macrophages and systemic infection in mice. Moreover, we found that xylose utilization by intracellular Salmonella was activated by the cAMP-CRP complex upon detection of low glucose levels in the infected macrophages. Collectively, these findings reveal that although the available glucose decreases during infection, Salmonella can use xylose, which accumulates in infected macrophages, as an alternative carbon source to promote intracellular replication and virulence.KEYWORDS: Salmonella, xylose utilization, macrophages, intracellular replication, virulence Introduction Salmonella is an important Gram-negative, food-borne intestinal pathogen, causing disease ranging from self-limited gastroenteritis to life-threatening systemic disease (e.g. typhoid fever) [1–3]. With more than 2,600 Salmonella serovars reported to date [4], Salmonella infection remains a major public health concern worldwide. People living in developing countries with harsh environments or weakened immune systems are more likely to develop severe infections [5]. Globally, approximately 93.8 million cases of gastroenteritis and 27 million cases of systemic diseases caused by Salmonella occur each year, resulting in more than 355,000 deaths [6,7]. Two essential steps are involved in Salmonella pathogenesis: invasion into non-phagocytic epithelial cells of the intestine, and survival and replication within host macrophages [8]. The ability to survive and replicate in macrophages is critical for Salmonella to establish a systemic infection in a susceptible host [9–11]. After uptake by macrophages, Salmonella resides and replicates within a modified phagosome, known as a Salmonella-containing vacuole (SCV) [12,13]. The formation and persistence of SCVs rely on effectors secreted by the Salmonella pathogenicity island (SPI)-2 type III secretion system (T3SS) [14,15]. Because the nutrients in macrophage SCVs are limited, the availability of nutrients represents a central requirement for Salmonella intracellular replication within SCVs [16,17]. SPI-2 effectors induce the formation of tubular structures growing out of the SCV, called Salmonella-induced filaments (SIFs), which result in a massive increase in the membrane surface and luminal volume of the SCV. This enables Salmonella to acquire host nutrients more efficiently [15,18]. Due to the scarcity of individual nutrients, Salmonella simultaneously uses diverse host nutrients, such as glucose, glycerol, fatty acids, N-acetylglucosamine (GlcNAc), gluconate, 3-phosphoglycerate (3-PG) and arginine, at the same time for efficient intracellular replication [19]. D-xylose, which is primarily derived from lignocellulose, is the second most abundant sugar in nature [20]. In animals, particularly mammals, xylose is widely presented in glycosaminoglycans and partial glycoproteins, but mammals themselves cannot metabolize xylose. Several bacteria have the ability to utilize xylose as a fermentable substrate, including Salmonella and its closely related model bacteria Escherichia coli [21]. In E. coli, xylose assimilation is achieved mainly through the high-affinity ATP-binding cassette transporter XylFGH. However, xylFGH genes are absent from the Salmonella genome, suggesting Salmonella employs other uncharacterized xylose transporter(s) for xylose uptake [22]. After uptake, xylose is directly converted to xylulose by the xylose isomerase XylA, which is then phosphorylated to xylulose-5-phosphate by the xylulokinase XylB [23]. Xylulose-5-phosphate is further metabolized via the pentose phosphate pathway (PPP) and glycolysis. The uptake and utilization of xylose are activated by the transcriptional regulator, XylR, which stimulates the transcription of xylose transporter genes (xylFGH) and xylose catabolic genes (xylA and xylB) in E.coli [24]. However, xylose utilization is repressed in the presence of glucose due to the global regulatory mechanism of carbon catabolite repression (CCR) [25]. Although Salmonella can use xylose as the sole carbon source, it is currently unknown whether xylose utilization contributes to its pathogenicity and intracellular growth of Salmonella. In this study, we assessed xylose levels in macrophages during Salmonella infection and the impact of xylose utilization on the intracellular replication and pathogenicity of Salmonella. We demonstrated that xylose levels are increased in Salmonella-infected macrophages and that the utilization of macrophage-derived xylose promotes Salmonella replication within macrophages and the colonization of mouse systemic loci. Because macrophage glucose levels decrease during Salmonella infection, the utilization of accumulated cellular xylose may be an important virulence strategy for Salmonella intracellular growth. Materials and methods Bacterial strains, plasmids and growth conditions The bacterial strains and plasmids used in this study are listed in Table S1. Salmonella enterica serovar Typhimurium ATCC 14028s was used as the wild type (WT) strain in this study. Salmonella strains were grown to stationary phase at 37°C in Luria-Bertani (LB) broth (1% [w/v] tryptone, 0.5% [w/v] yeast extract, and 0.5% [w/v] NaCl) with aeration for infection of macrophages and mouse infection assays. Cultures grown overnight in LB medium were diluted 1:100 into fresh N-minimal medium (80 mm MES pH 5.8, 5 mm KCl, 7.5 mm (NH4)2SO4, 0.5 mm K2SO4, 38 mm glycerol, 0.1% [w/v] casamino acids, 10 mm MgCl2, and 110 mm KH2PO4) and incubated at 37°C with shaking (180 rpm) until reaching stationary phase (OD600 ~0.6) for quantitative real-time PCR (qRT-PCR) analysis. Growth in minimal medium was conducted in M9 (47.9 mm Na2HPO4, 17.2 mm KH2PO4, 8.55 mm NaCl, 18.7 mm NH4Cl) with 5 mg/mL xylose as the sole carbon source. Antibiotics were added at the following final concentrations: 25 µg/mL chloramphenicol (Cm), 50 µg/mL kanamycin (Km), and 100 µg/mL ampicillin (Amp), 10 µg/mL Tetracycline (Tc). Construction of strains and plasmids The primers used in this study are listed in Table S2. Mutant strains (e.g. ΔxylAB, ΔxylR and Δcrp) of WT and complementation strains of the crp mutant (Δcrp+) were generated using the λ Red recombination system [26]. The complemented stains of the xylAB and xylR mutants were generated by cloning xylAB or xylR gene and the respective promoter sequence into the low-copy plasmid pACYC184. All conducted strains were verified by PCR amplification and targeted sequencing. Primers for PCR amplification and targeted sequencing were designed at ~ 200 bp upstream and ~ 200 bp downstream of the gene sequence intended for deletion. The pET28a-crp plasmid used for the purification of the CRP-His6 protein was generated as previously described [27]. Cell culture The mouse macrophage cell line RAW264.7 (ATCC TIB71) was obtained from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China) and cultured in RPMI-1640 medium supplemented with 10% [v/v] heat-inactivated fetal bovine serum (FBS) at 37°C with 5% CO2. Macrophage infections At 24 h before infection, Raw264.7 cells were seeded in 24-well culture plates at a density of 1 × 105 cells/well and maintained as differentiated monolayers. The Salmonella WT and mutant strains grown overnight to stationary phase (OD600 ~2.0) in LB medium at 37°C were serially diluted to 1 × 106 colony-forming units (CFUs)/mL, opsonized in RPMI-1640 medium containing 10% heat-inactivated FBS for 30 min, and then added to macrophage monolayers at a multiplicity of infection (MOI) of 10. The plates were centrifuged at 500 × g for 5 min to synchronize bacterial uptake and incubated for 45 min at 37°C with 5% CO2/95% air. After infection, the cells were washed thrice with phosphate-buffered saline (PBS) and incubated in RPMI-1640 medium containing 100 μg/mL Gm to remove extracellular bacteria. The cells were then incubated in an RPMI-1640 medium containing 10 μg/mL Gm for the remainder of the experiment. At 2 and 20 h post-infection after Gm treatment, the infected cells were washed with PBS and lysed with 1% [v/v] Triton X-100. Intracellular bacteria were enumerated on LB plates for CFU analysis. The fold intracellular replication of Salmonella strains was determined by dividing the intracellular bacterial load recovered at 20 h by that recovered at 2 h. Mouse infections Six-to eight-week-old female BALB/c mice (a commonly used mouse model to study the pathogenesis of S. Typhimurium infection) weighing 18–20 g were purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd. (Beijing, China) and used for infection. Mice were maintained under specific pathogen-free conditions, with a 12 h light – dark cycle (temperature: 24°C ±2°C; relative humidity: 50% ± 5%). All the experimental procedures were approved by the Institutional Animal Care Committee of Nankai University (2021-SYDWLL-000029), Tianjin, China. ARRIVE guidelines were followed in this study [28]. To determine the bacterial numbers in the liver and spleen, a total of 45 mice were randomly divided into different infection groups (5 to 9 mice per group) and were infected by intraperitoneal (i.p.) injection with ~ 104 CFUs of Salmonella WT, mutant strains, or complemented strains in PBS. Mice i.p. injected with equivalent dosage of PBS were used as a negative control group. On day 3 post-infection, the infected mice were sacrificed. The liver and spleen were collected, homogenized in cold PBS, serially diluted, and plated on LB agar plates to obtain CFUs/gram of tissue. For competitive infection, mice (8 mice per group) were injected i.p. with a 1:1 mix of two strains (WT and ΔxylAB, or WT and ΔxylR; ~104 total CFUs) and were euthanized on day 3 post-infection. The liver and spleen were collected, homogenized in cold PBS, serially diluted, and plated on LB agar plates without antibiotics or containing 25 µg/mL Cm to determine bacterial CFUs. The CI value was calculated as (CFUs WT recovered/CFUs mutant strain recovered)/(CFUs WT inoculated/CFUs mutant strain inoculated). Mouse infection assays were conducted twice by two different researchers, with at least 2 mice in each injection group, and the combined data for the two independent experiments was used for statistical analysis. Measurement of xylose concentration To assess xylose levels in RAW264.7 macrophages, cells were left uninfected or infected with Salmonella WT or mutant strains for 20 h, followed by lysis through repeated freeze-thaw cycles. The supernatants of cell lysates were collected by centrifugation and used for measuring xylose concentration. The xylose concentration was measured using a D-Xylose Content Assay Kit (Solarbio, BCC4395) according to the manufacturer’s instructions. D-xylose hydrolyzes under strong acidic conditions to produce furfural, which can react with phloroglucinol to form a pink compound with a special absorption peak at 554 nm. Based on this, the content of xylose in the sample can be calculated from the absorbance value. The concentrations of xylose in each sample can be calculated by measuring its absorbance at 554 nm. RNA isolation and qRT-pcr analysis Total RNA was isolated using the RNAsimple Total RNA Kit (TIANGEN Biotech, DP419), and cDNA was synthesized using the StarScript III RT Master Mix (Genstar, A233) according to the manufacturer’s instructions. Each 20 μL qRT-PCR reaction system contained 1 μL of cDNA, 10 μM of each primer, and 10 μL of 2 × RealStar Power SYBR qPCR Mix (Genstar, A314). The qRT-PCR was run on a QuantStudio Real-Time PCR Systems (Thermo Fisher Scientific) using the following program: 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for 30 s. Expression of target genes was normalized to 16s RNA as a control. Relative changes in gene expression were analyzed using the comparative cycle threshold (ΔΔCt) method [29]. Electrophoretic mobility shift assay (EMSA) The CRP-His6 fusion protein was expressed in Escherichia coli BL21 cells containing the pET28a-crp plasmid, purified using a Ni-NTA column and detected by SDS-PAGE. The protein concentration was determined using a BCA Protein Assay Kit (Genstar, E162), and the protein was used for EMSA. PCR fragments encompassing the regulatory region of xylR were amplified using the genomic DNA of the WT strain as a template, and the negative control (Km fragment) was amplified using pKD4. Purified DNA (50 ng) was preincubated with various concentrations of purified protein (0–1 mm) in a 20 μL solution in the presence or absence of 0.2 mm cAMP containing the binding buffer (20 mm Tris-HCl [pH 7.5], 50 mm KCl, 1 mm DTT, and 10% glycerol [v/v]) at 37°C for 30 min. The mixtures were dyed with 10 × DNA loading buffer and separated on a 6% native PAGE gel in 0.5× TBE at 120 V for 90 min. The gels were stained with GelRed for 10 min and imaged using a gel imaging system (Tanon). Statistical analysis Data were analyzed using GraphPad Prism v9.5.1. The mean ± SD from three independent experiments is shown in the figures, unless otherwise indicated. Differences between the mean values were evaluated using a two-tailed unpaired Student’s t-test, one-way analysis of variance (ANOVA), and two-way ANOVA. Significant differences between the groups are represented as *p < 0.05, **p < 0.01, and ***p < 0.001, respectively. ns, indicates no statistically significant difference (p > 0.05). Results Salmonella infection increases xylose levels in infected macrophages To determine the changes in xylose levels in macrophages after Salmonella infection, we measured xylose concentrations in the mouse macrophage cell line RAW264.7, which was left uninfected or infected with wild-type Salmonella (Salmonella enterica serovar Typhimurium ATCC 14028s, WT). At 20 h post-infection, the xylose levels of RAW264.7 cells increased 1.96-fold relative to those of uninfected macrophages (Figure 1), indicating that Salmonella infection enhanced xylose accumulation inside macrophages. Salmonella infection increases xylose levels in infected macrophages. Xylose concentrations in RAW264.7 cells that were uninfected (UN) or those infected with salmonella WT (salmonella typhimurium ATCC 14028s) for 20 h. Data are presented as mean ± SD of three independent experiments. p value was determined using two-tailed unpaired Student’s t-test. *p < 0.05. Salmonella enhances its xylose utilization inside macrophages Before investigating the physiological function of xylose in Salmonella, we measured the expression levels of Salmonella xylose catabolic genes (xylA and xylB) and a transcriptional regulatory gene for xylose metabolism (xylR) (Figure 2(a)) using quantitative real-time PCR (qRT-PCR) analysis. Compared to bacterial growth in RPMI-1640 medium, expression of the xylA, xylB, and xylR genes increased 5.04-, 4.36-, and 4.68-fold, respectively, 8 h after infection with RAW264.7 cells (Figure 2(b)). These results suggest that Salmonella enhances its xylose utilization inside macrophages, implying that Salmonella uses the accumulated macrophage xylose for intracellular growth. Salmonella enhances its xylose utilization inside macrophages. (a) Scheme of the xylose metabolic pathway in Salmonella. (b) qRT-pcr analysis the mRNA levels of salmonella xylose catabolic genes (xylA, xylB), and the transcriptional regulatory gene of xylose metabolism xylR. RAW264.7 cells were infected with salmonella WT for 8 h (MOI = 10). The cells were then lysed, and the intracellular bacteria were collected for RNA extraction and qRT-pcr. RNA extracted from bacteria in RPMI-1640 medium served as a control. Fold changes in xylA, xylB and xylR intracellular expression at 8 h post-infection relative to its expression in RPMI-1640 medium are presented. Data are presented as mean ± SD of three independent experiments. p values were determined using one-way ANOVA. *p < 0.05, **p < 0.01. Xylose utilization promotes salmonella replication within macrophages To explore whether xylose utilization influence Salmonella replication in macrophages, we generated the Salmonella mutant strains of the xylose catabolic gene xylAB (ΔxylAB) and the transcriptional regulatory gene of xylose metabolism xylR (ΔxylR). ΔxylAB and ΔxylR mutants were unable to grow in M9 minimal medium with xylose as the sole carbon source (Figure 3(a)), revealing that XylAB and XylR are essential for the xylose utilization of Salmonella. We also examined the xylose levels in macrophages infected with the mutant strains ΔxylAB and ΔxylR. The inability of the mutant strains to utilize xylose likely leads to increased accumulation of xylose in macrophages. Our results showed that the mean xylose levels are slightly elevated in ΔxylAB- and ΔxylR-infected macrophages, compared to WT-infected macrophages, but the difference is not statistically significant (Figure S1). It is known that the volume of Salmonella is considerably smaller than that of the macrophages and our recent research has demonstrated that approximately 94% of the infected macrophages contained no more than ten bacteria at 8 h post-infection [27]. Given this information, we speculate that a small portion of intracellular xylose may be utilized by Salmonella, which could account for the similar levels of xylose in WT- and the mutants-infected macrophages. Xylose utilization promotes salmonella replication within macrophages. (a) Growth curves of salmonella WT, ΔxylAB, and ΔxylR in M9 minimal medium with xylose (5 mg/mL, 33.3 mm) as the sole carbon source. (b) Replication of salmonella WT, mutant strains (ΔxylAB, ΔxylR) and complemented strains (cΔxylAB, cΔxylR) in RAW264.7 cells. RAW264.7 cells were infected with bacteria at an MOI of 10. The bacterial replication rate was determined by the ratio of the number of intracellular bacteria at 20 h post-infection to the number of bacteria at 2 h post-infection. (c) Growth curves of salmonella WT, mutant strains (ΔxylAB, ΔxylR) and complemented strains (cΔxylAB, cΔxylR) in LB (left panel) and RPMI 1640 medium (right panel). Data are presented as mean ± SD of three independent experiments (a-c). p values were determined using one-way ANOVA (b). ***p < 0.001; ns, not significant. Subsequently, we examined the intracellular replication ability of the mutant strains in RAW264.7 macrophages. Gentamicin protection assays showed that the replication ability of ΔxylAB and ΔxylR in RAW264.7 cells was reduced 3.16- and 2.13-fold respectively (p < 0.05) compared with that of the WT strain (Figure 3(b)), while genetic complementation of the ΔxylAB and ΔxylR mutations restored their intracellular replication to WT level (Figure 3(b)), indicating that xylose utilization contributed to Salmonella growth in macrophages. The growth rates of ΔxylAB and ΔxylR in LB medium and RPMI-1640 medium resembled that of the WT strain (Figure 3(c)), indicating that the impaired intracellular replication ability of the mutants was not due to growth defects. These data indicate that xylose accumulated inside the macrophages can be utilized by Salmonella to promote intracellular replication. Xylose utilization contributes to Salmonella systemic infection in mice Replication in macrophages is required for Salmonella systemic infection, and Salmonella mainly replicates in the macrophages of liver and spleen to increase their numbers so as to cause lethal infection [30–33]. The results above reveal that xylose utilization facilitates Salmonella replication within macrophages, we hypothesized that xylose utilization might also influence Salmonella virulence in vivo. To test the effect of xylose on Salmonella systemic virulence, we infected BALB/c mice by i.p. injection with ~ 104 WT, mutant strains (ΔxylAB, ΔxylR) and complemented strains (cΔxylAB, cΔxylR). We then measured the colonization difference between these strains in mouse systemic loci (liver and spleen) at day 3 post-infection (Figure 4(a)). We observed that the bacterial counts in WT-infected mice reached ~ 105 in the liver and ~ 106 in the spleen on day 3 post-infection, implying WT is extensively replicated in the macrophage of the mouse liver and spleen; while in ΔxylAB- and ΔxylR- infected mouse liver and spleen, the bacterial counts (liver: ~104; spleen: ~105) was significantly (p < 0.01) decreased compared to those of the WT-infected mice (Figure 4(b)). Complementation of the ΔxylAB and ΔxylR mutants restored their colonization ability in mouse liver and spleen to WT level (Figure 4(c)). Moreover, we performed competition assays in BALB/c mice to evaluate the capacity of Salmonella WT and the mutant strains (ΔxylAB, ΔxylR) to utilize xylose in vivo. The results showed that ΔxylAB and ΔxylR were significantly (p < 0.05) outcompeted by the WT strain in liver and spleen of the infected mice (Figure 4(d)), revealing that due to xylose utilization, WT had a growth advantage over the mutant strains in mouse systemic loci. These results suggested that xylose utilization contributes to Salmonella systemic infection in mice. Xylose utilization contributes to Salmonella colonization of mouse systemic loci. (a) Schematic illustration of the mouse infection assays. (b) BALB/c mice were infected by i.P. injection with Salmonella WT (n = 9 mice), ΔxylAB (n = 8 mice), or ΔxylR (n = 8 mice), and sacrificed on day 3 post-infection for enumeration of bacterial burdens in livers (left panel) and spleens (right panel). (c) BALB/c mice were infected by i.P. injection with Salmonella WT or complemented strains (cΔxylAB, cΔxylR) and sacrificed on day 3 post-infection for enumeration of bacterial burdens in livers (left panel) and spleens (right panel). n = 5 mice per group. (d) Competitive index of the Salmonella WT versus ΔxylAB (left panel) or ΔxylR (right panel) in the liver and spleen of infected mice. BALB/c mice were infected by i.P. injection with a 1:1 mix of Salmonella WT and mutant strains, and were sacrificed on day 3 post-infection for enumeration of bacterial burdens. The CI values were determined in the liver and spleen. n = 8 mice per group. p values were determined using Mann – Whitney U test (b – c). For (d), p values were determined using two-tailed paired Student’s t-test on raw CFU values. *p < 0.05, **p < 0.01, ***p < 0.001; ns, not significant. cAMP-crp complex activates XylR and XylAB We investigated the upstream regulatory system to clarify how xylAB and xylR were induced during Salmonella growth in macrophages. Using the BPROM program (http://www.softberry.com/), we identified a putative cAMP receptor protein (CRP)-binding site in the promoter region of xylR, indicating that CRP is a potential regulator of XylR. CRP is an important global regulator of genes involved in carbon source utilization in bacteria. CRP performs its regulatory function by binding to cAMP to form the CRP-cAMP complex, which in turn binds to specific DNA sequences within target promoters [34]. We generated a mutant strain of the crp gene (Δcrp) and then tested the influence on the expression of xylR and its downstream xylAB genes upon crp mutation. qRT-PCR analysis showed that the mutation of crp significantly (p < 0.05) decreased the mRNA levels of xylR, xylA, and xylB. Complementation of Δcrp by the expression of a functional crp gene restored the mRNA levels of xylR, xylA, and xylB to the WT level (Figure 5(a)). These results indicate that CRP positively regulates the expression of xylR and its downstream xylA and xylB genes. xylAB and xylR are positively regulated by CRP. (a) The salmonella WT strain, the crp mutant Δcrp, and the complemented strain Δcrp+ were grown in N-minimal medium until they reached the stationary phase. Transcript levels of xylR, xylA, and xylB in different strains were assessed by qRT-pcr. Fold changes in gene transcription in the mutant and complemented strains relative to their expression in the WT are presented. Data are presented as mean ± SD of three independent experiments. p values were determined using two-way ANOVA. **p < 0.01, ***p < 0.001; ns, not significant. (b) EMSA of the xylR promoter DNA fragments with purified CRP-His6 protein (0, 0.25, 0.5, 0.75, 1, and 1.25 µm) in the presence or absence of 0.2 mm cAMP. Kanamycin DNA fragment was used as a negative control. Images are representative of three independent experiments. Full gels of the EMSA are shown in figure S2. Using electrophoretic mobility shift assay (EMSA), we tested whether CRP bound to the promoter region of xylR. We found that when CRP protein concentrations were 0.75, 1.0, and 1.25 μM, the delayed bands of the xylR promoter DNA were detected in the presence of 0.2 mm cAMP. Additionally, in the absence of cAMP, the binding requires higher protein amounts than binding in the presence of cAMP, as a delayed band was only detected when the CRP protein concentration reached 1.25 μM, implying that cAMP improves CRP binding to the xylR promoter (Figures 5(b), S2). The kanamycin DNA fragment was used as a negative control to exclude the possibility of non-specific binding between the CRP protein and xylR promoter. As expected, with increasing concentrations of CRP protein, no delayed bands of the kanamycin DNA fragment were detected in the presence or absence of 0.2 mm cAMP (Figures 5(b), S2). These results indicate that CRP directly regulates the expression of xylR, and that cAMP promotes the regulation of xylR by CRP. Discussion Despite being confined to a membrane-bound compartment-SCV within macrophages and the limited nutrient availability inside the SCV, Salmonella can rapidly replicate in macrophages using diverse host nutrients at the same time [27,35]. However, the nutrients used by Salmonella for intracellular growth remain largely unknown. In this study, we established that xylose utilization contributes to Salmonella intracellular replication and pathogenicity. Mutation of xylose catabolic genes (xylA and xylB) or the transcriptional regulatory gene of xylose metabolism (xylR) reduces Salmonella growth in mouse macrophages and attenuates bacterial virulence in vivo. We observed that the xylose levels in macrophages increased during Salmonella infection, which may provide adequate xylose for access by intracellular Salmonella. We showed that xylose utilization in Salmonella is activated by the global regulator CRP because mutation of crp reduced the expression of xylA, xylB, and xylR. Moreover, we showed that CRP directly activated xylR expression by binding to the promoter region of xylR, which was promoted by cAMP. cAMP levels are negatively correlated with glucose concentrations [36]. During Salmonella infection, the availability of glucose inside macrophages is limited, and cAMP levels increase [27]. In turn, increased levels of Salmonella cAMP-CRP complex would promote the utilization of xylose by intracellular Salmonella. In other words, Salmonella begins to utilize xylose when the glucose level in macrophages decreases. Thus, although glucose is the preferred carbon source for intracellular Salmonella, the competition for glucose between Salmonella and the host reduces the intracellular concentrations of available glucose; therefore, the utilization of xylose, which accumulates during Salmonella infection, may be an important virulence strategy for the efficient replication of Salmonella in macrophages. We proposed a model for the utilization of xylose during Salmonella growth in macrophages (Figure 6). Salmonella infection decreases glucose concentration and increases xylose concentration in infected macrophages. The available glucose for intracellular Salmonella decreases, resulting in increased levels of bacterial cAMP and the cAMP-CRP complex. The cAMP-CRP complex activates XylR expression, which further activates the expression of xylose catabolic genes (xylA and xylB) and xylose transporter genes, leading to xylose uptake from the host. The utilization of xylose promotes Salmonella replication inside macrophages and systemic infections in mice. Our findings provide a significant example of how alternative carbon sources facilitate Salmonella pathogenicity. However, the xylose transporter genes in Salmonella are currently unknown and require further study. Schematic model for the utilization of xylose during salmonella growth in macrophages. salmonella infection leads to the decrease of glucose concentrations and the increase of xylose concentrations in infected macrophages. The available glucose for intracellular salmonella is decreased, resulting in increased levels of bacterial cAMP and cAMP-crp complex. cAMP-crp complex activates salmonella utilization of xylose. The utilization of xylose promotes salmonella replication inside macrophages and its systemic infection in mice. In E. coli, xylose is primarily assimilated through the high-affinity transporter, XylFGH, encoded by the gene cluster xylFGH, although a low-affinity proton symporter, XylE (encoded by xylE), is also present [37]. The xylose catabolic gene xylAB and the transcriptional regulatory gene of xylose metabolism (xylR) were present in the genome of closely related E. coli and Salmonella, whereas both xylFGH and xylE were absent in the Salmonella genome. Since Salmonella has the ability to use xylose as the sole carbon source for growth [22], other unknown xylose transporters in Salmonella must be present for xylose uptake. Overall, our observations demonstrate that xylose utilization contributes to Salmonella replication within macrophages and to systemic infection in mice. Xylose utilization by Salmonella inside macrophages is activated by decreased glucose levels and increased levels of the cAMP-CRP complex. We speculate that xylose accumulation in Salmonella-infected macrophages provides a sufficient carbon source for intracellular Salmonella. In recent years, an increasing number of cellular metabolites have been identified can be utilized by Salmonella as nutrients to grow in macrophages. Therefore, as a highly successful intracellular pathogen, Salmonella can exploit a variety of host-derived nutrients to facilitate its infection of the host. Supplementary Material Figure S2.tif Table S1.docx Table S2.docx Supplementary_material.docx Author_Checklist_Jiang.pdf Figure S1.tif Funding Statement This work was supported by the National Natural Science Foundation of China (NSFC) Program (grant no. 32170110, 32270191), the Natural Science Foundation of Tianjin (grant no. 22JCYBJC01060), and the Fundamental Research Funds for the Central Universities, Nankai University (grant no. 63241588, 63243161). The funders had no role in the study design, data collection and analysis, and manuscript preparation. Disclosure statement No potential conflict of interest was reported by the author(s). Author contributions Conceptualization, L.J., B.Y., and X.W.; data curation, X.W. and L.J.; formal analysis, X.W. and L.J.; funding acquisition, L.J.; investigation, X.W., Y.S., H.G., X.Y., and S.M.; methodology, X.W., and L.J.; project administration, X.W. and L.J.; resources, L.J. and B.Y.; supervision, L.J.; validation, Y.S., H.G., X.Y., and S.M.; validation, X.W. and L.J.; writing – original draft preparation, X.W. and L.J.; writing – review and editing, L.J. and B.Y. All authors have read and agreed to the published version of the manuscript. Data availability statement The data that support the findings of this study are openly available in Zenodo (https://doi.org/10.5281/zenodo.13850464) Supplementary material Supplemental data for this article can be accessed online at https://doi.org/10.1080/21505594.2024.2435381 References Associated Data Supplementary Materials Figure S2.tif Table S1.docx Table S2.docx Supplementary_material.docx Author_Checklist_Jiang.pdf Figure S1.tif Data Availability Statement The data that support the findings of this study are openly available in Zenodo (https://doi.org/10.5281/zenodo.13850464)